Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 3,007Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 10VIIV HLTHCARE

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

CABOTEGRAVIR; RILPIVIRINE

US Patent Number : 7125879

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 212888

Patent Use Code : U-3348

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2025-04-21

blank

02

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

CABOTEGRAVIR; RILPIVIRINE

US Patent Number : 11224597

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 212888

Patent Use Code : U-3348

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-09-15

blank

03

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

CABOTEGRAVIR; RILPIVIRINE

US Patent Number : 11224597

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 212888

Patent Use Code : U-3348

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-09-15

blank

04

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

CABOTEGRAVIR; RILPIVIRINE

US Patent Number : 8410103

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 212888

Patent Use Code : U-3348

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-04-28

blank

05

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

CABOTEGRAVIR; RILPIVIRINE

US Patent Number : 8410103

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 212888

Patent Use Code : U-3348

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-04-28

blank

06

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

CABOTEGRAVIR; RILPIVIRINE

US Patent Number : 11389447

Drug Substance Claim :

Drug Product Claim :

Application Number : 212888

Patent Use Code : U-3405

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-06-30

blank

07

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

CABOTEGRAVIR; RILPIVIRINE

US Patent Number : 11389447

Drug Substance Claim :

Drug Product Claim :

Application Number : 212888

Patent Use Code : U-3405

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-06-30

blank

08

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

CABOTEGRAVIR; RILPIVIRINE

US Patent Number : 7125879

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 212888

Patent Use Code : U-3348

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2025-04-21

blank

09

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

CABOTEGRAVIR; RILPIVIRINE

US Patent Number : 10927129

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 212888

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-04-28

blank

10

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

CABOTEGRAVIR; RILPIVIRINE

US Patent Number : 10927129

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 212888

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-04-28

blank